Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
12/08/2026 18:47
BRIEF-China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN Aug 12 (Reuters) - China Biotech Services Holdings Ltd 8037.HK:
EXPECTS NET PROFIT OF NOT LESS THAN HK$15.0 MILLION FOR SIX MONTHS ENDED JUNE 30, 2026
EXPECTED HY NET PROFIT MAINLY DUE TO FAIR VALUE GAIN ON CONVERTIBLE BONDS OF HK$77-87 MILLION
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)